DEVELOPMENT OF A PATIENT DECISION AID BASED ON MULTI-CRITERIA DECISION ANALYSIS FOR DISEASE-MODIFYING DRUGS FOR MULTIPLE SCLEROSIS

被引:0
|
作者
Kremer, Ingrid [1 ]
Jongen, Peter [2 ]
Evers, Silvia [3 ]
Hoogervorst, Erwin [4 ]
Verhagen, Wim [5 ]
Hiligsmann, Mickael [3 ]
机构
[1] Maastricht Univ, Maastricht, Netherlands
[2] MS4 Res Inst, Nijmegen, Netherlands
[3] Maastricht Univ, Dept Hlth Serv Res, Care & Publ Hlth Res Inst CAPHRI, Maastricht, Netherlands
[4] St Antonius Hosp, Utrecht, Netherlands
[5] Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
PS2-19
引用
收藏
页码:E459 / E460
页数:2
相关论文
共 50 条
  • [1] Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development
    I. E. H. Kremer
    P. J. Jongen
    S. M. A. A. Evers
    E. L. J. Hoogervorst
    W. I. M. Verhagen
    M. Hiligsmann
    BMC Medical Informatics and Decision Making, 21
  • [2] Patient decision aid based on multi-criteria decision analysis for disease-modifying drugs for multiple sclerosis: prototype development
    Kremer, I. E. H.
    Jongen, P. J.
    Evers, S. M. A. A.
    Hoogervorst, E. L. J.
    Verhagen, W. I. M.
    Hiligsmann, M.
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2021, 21 (01)
  • [3] Agents based multi-criteria decision-aid
    Alba Amato
    Beniamino Di Martino
    Salvatore Venticinque
    Journal of Ambient Intelligence and Humanized Computing, 2014, 5 : 747 - 758
  • [4] Agents based multi-criteria decision-aid
    Amato, Alba
    Di Martino, Beniamino
    Venticinque, Salvatore
    JOURNAL OF AMBIENT INTELLIGENCE AND HUMANIZED COMPUTING, 2014, 5 (05) : 747 - 758
  • [5] Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs
    Alnaqbi, Khalid A.
    Elezbawy, Baher
    Fasseeh, Ahmad N.
    Bangash, Abdul Rauf
    Elshamy, Amin
    Shendi, Hiba
    Aftab, Mohammed I.
    AlMarshoodi, Mozah
    Gebran, Nicole
    AlDhaheri, Noura
    Fahmy, Sahar A.
    Al Dallal, Sara
    Al Naeem, Waeil
    Abaza, Sherif
    Kalo, Zoltan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [6] Development of a decision aid for patients with multiple sclerosis considering disease modifying drug therapy
    Porter, B
    Giovannoni, G
    Mynors, G
    Miller, DH
    Keenan, E
    Tate, J
    Russell, A
    Thompson, A
    Short, D
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S136 - S136
  • [7] Discontinuation Of Prolonged Disease-modifying Treatments In Multiple Sclerosis: A Difficult Decision
    Tuncer, A.
    Ozen, P. Acar
    Karabudak, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 65 - 65
  • [8] Use of Disease-Modifying Drugs in Multiple Sclerosis
    Wurzius, F. Q.
    Silva, C. B.
    de Vecino, M. A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 102 - 103
  • [9] Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
    Utz, Kathrin S.
    Hoog, Jana
    Wentrup, Andreas
    Berg, Sebastian
    Laemmer, Alexandra
    Jainsch, Britta
    Waschbisch, Anne
    Lee, De-Hyung
    Linker, Ralf A.
    Schenk, Thomas
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (06) : 263 - 275
  • [10] Review on multi-criteria decision analysis aid in sustainable energy decision-making
    Wang, Jiang-Jiang
    Jing, You-Yin
    Zhang, Chun-Fa
    Zhao, Jun-Hong
    RENEWABLE & SUSTAINABLE ENERGY REVIEWS, 2009, 13 (09): : 2263 - 2278